—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Viking Therapeutics Inc (VKTX) — Technical state

As of 2026-11-09 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 28 out of 100 (momentum 29 · quality 2), as of 2026-11-11.
  • Signal: Up 8% at the close — one of the day's strongest moves. (as of 2026-11-09)
  • Trend: Viking Therapeutics Inc trades 2.5% below its 50-day and 10.0% below its 200-day moving average. (as of 2026-11-09)
  • Index seat: HALO Growth 100

Viking Therapeutics is a clinical-stage biopharmaceutical company developing treatments for metabolic and endocrine disorders. Its lead programme is an oral thyroid hormone receptor beta agonist being tested against liver disease, alongside a selective androgen receptor modulator for post-fracture recovery and a dual GLP-1 agonist in early-stage trials.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the VKTX overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Up 8% at the close

one of the day's strongest moves.

The moving-average stack

Continue: the VKTX chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-11-09

Quick answers

What is the current Closelooknet signal on VKTX?

Up 8% at the close — one of the day's strongest moves. As of 2026-11-09; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is VKTX above its 50-day and 200-day moving averages?

As of 2026-11-09, Viking Therapeutics Inc trades -2.5% below its 50-day and -10% below its 200-day average, with the 20-day +10.6% away.

How far is VKTX from its 52-week high?

32.8% below the 52-week high and 21.7% above the 52-week low, as of 2026-11-09.

Related in the Closelooknet universe

same Closelooknet index seat first, then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.